Related Experiment Video
Updated: Jun 12, 2025

11:28
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.5K
PATH classification: a proposal for patients with HNSCC treated with salvage surgery
Albert Llansana1, David Virós Porcuna2, Rosselin Vasquez3
1Otorhinolaryngology Department, Hospital Mutua de Terrassa, Universitat Autonoma, Terrassa, Spain.
Summary
A new PATH classification for recurrent head and neck squamous cell carcinoma (HNSCC) patients undergoing salvage surgery offers improved prognostic accuracy. This classification better stratifies patients and predicts outcomes compared to the existing rpTNM system.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Staging
Background:
- Recurrent head and neck squamous cell carcinoma (HNSCC) presents a significant clinical challenge.
- Salvage surgery is a critical treatment option for patients with recurrent HNSCC.
- Accurate prognostic classification is essential for guiding treatment decisions and patient counseling.
Purpose of the Study:
- To propose a novel postoperative classification system for recurrent HNSCC patients undergoing salvage surgery.
- To evaluate the prognostic capacity of the proposed classification compared to the current rpTNM system.
Main Methods:
- Retrospective analysis of 665 patients with HNSCC treated with salvage surgery for local and/or regional recurrence.
- Development of the PATH (Primary tumor location, Pathologic extension, Tumor margins, and Extracapsular spread) classification.
- Comparison of prognostic discrimination between the PATH classification and the rpTNM classification.
Main Results:
- The PATH classification stratifies patients into 4 stages based on primary tumor site, pathologic extension, margin status, and lymph node extracapsular spread.
- The PATH classification demonstrated more homogeneous prognosis within stages and superior prognostic discrimination compared to rpTNM.
- Five-year disease-specific survival rates varied significantly across PATH stages (82.8% for PATH I to 3.7% for PATH IV), outperforming rpTNM staging.
Conclusions:
- The proposed PATH classification offers a more accurate prognostic tool for recurrent HNSCC patients undergoing salvage surgery.
- This new system provides better prognostic stratification and discrimination than the rpTNM classification.
- The PATH classification can aid in optimizing treatment strategies and predicting outcomes for this patient population.

